Literature DB >> 1992968

Occlusive vasculopathy in systemic lupus erythematosus. Association with anticardiolipin antibody.

S G Greisman1, R S Thayaparan, T A Godwin, M D Lockshin.   

Abstract

Patients with systemic lupus erythematosus and with antiphospholipid antibody are subject to sudden occlusion of multiple blood vessels. We describe two patients with systemic lupus erythematosus with acute, catastrophic, widespread non-inflammatory visceral vascular occlusions associated with high-titer antiphospholipid antibody. The histopathologic features clearly distinguished these patients from classic systemic lupus erythematosus vasculitis. We further suggest that, based on a probable pathogenesis related to the presence of antiphospholipid antibody, and based on the non-inflammatory vascular occlusion, steroids and other immunosuppressive medications are of limited value. Plasmapheresis along with anticoagulant therapy should be considered.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1992968

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  11 in total

Review 1.  Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients.

Authors:  R Cervera; R A Asherson; M L Acevedo; J A Gómez-Puerta; G Espinosa; G De La Red; V Gil; M Ramos-Casals; M García-Carrasco; M Ingelmo; J Font
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

Review 2.  The antiphospholipid syndrome: a syndrome in evolution.

Authors:  R A Asherson; R Cervera
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

3.  Segmental small bowel necrosis associated with antiphospholipid syndrome: a case report.

Authors:  Qun-Ying Wang; Xiao-Hua Ye; Jin Ding; Xiao-Kang Wu
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

4.  Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome.

Authors:  M G Tektonidou; J P Ioannidis; I Moyssakis; K A Boki; V Vassiliou; P G Vlachoyiannopoulos; M K Kyriakidis; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2001-01       Impact factor: 19.103

5.  Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  F M K Williams; S Chinn; G R V Hughes; R M Leach
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

Review 6.  Gastrointestinal hemorrhage and intestinal ischemia associated with anticardiolipin antibodies.

Authors:  M S Cappell; N Mikhail; N Gujral
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

7.  Lack of correlation between anticardiolipin antibodies and peripheral autonomic nerve involvement in systemic lupus erythematosus.

Authors:  M Magarò; L Mirone; L Altomonte; A Zoli; S Angelosante
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

8.  Lupus anticoagulant (LA) in pregnant women with history of recurrent fetal loss.

Authors:  Ja Olaniyi; Sa Olomu; Oa Finomo
Journal:  J Blood Med       Date:  2011-05-30

9.  Lethal End of Spectrum of Clots-Thrombotic Storm.

Authors:  Muhammad Asim Rana; Ahmed F Mady; Abdullah Ali Lashari; Rehab Eltreafi; Nicola Fischer-Orr; Kamal Naser
Journal:  Case Rep Crit Care       Date:  2018-05-27

Review 10.  [Antiphospholipid antibody syndrome].

Authors:  R Schmidt; E H Scheuermann; A Viertel; H Geiger; I Scharrer
Journal:  Med Klin (Munich)       Date:  1999-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.